维普中文期刊产品整合服务
10篇 您的检索式:作者名="Croucher MJ"
    题名 作者 年代 出处 被引量
1Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease:evidence for decreased osteolysis,tumor burden and angiogenesis and increased survival显示文摘Croucher PI De Hendrik R Perry Mj 2003J Bone Miner Res2003,18,3:1
2Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis,tumor burden and angiogenesis, and increased survival显示文摘Croucher PI De Hendrik R Perry MJ 2003J Bone Miner Res2003,18,3:1
3Bisphosphonates : pharmacology, mechanisms of action and clinical uses 显示文摘Russell RG Croucher PL Rogers MJ 1999Osteoporos Int1999,9,2:1
4NMDA receptor blockade inhibitsglutamate-induced kindling of the rat amygdala显示文摘Croucher MJ Bradford HF 1990Brain Res1990,506,2:1
5Bisphosphonates: pharmacology, mechanisms of action and clinical uses 显示文摘Russell RG Croucher PI Rogers MJ 1999Osteoporos Int1999,9,2:1
6Additive neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson's model 显示文摘Vernon AC Croucher MJ Dexter DT 2008Neuroreport2008,19,4:1
7Bisphosphonates: pharmacology, mechanisms of action and clinical uses 显示文摘Russell RG Croucher PI Rogers MJ 1999Osteoporos Int1999,92,:1
8Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival显示文摘Croucher PI De Hendrik R Perry MJ 2003J Bone Miner Res2003,18,:1
9Bisphosphonates: pharmacology, mechanisms of action and clinical uses显示文摘Russell RG Croucher PI Rogers MJ 1999Osteoporos Int1999,9,:1
10Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamlne rodent model of Parkinson's disease显示文摘Vernon AC Palmer S Datla KP Zbarsky V Croucher MJ Dexter DT 2005Eur J Neurosci2005,22,7:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费